Therapeutic compositions for intranasal administration which include KETOROLAC.RTM.

US6333044A · kind A · utility

Assignee

• Recordati S.A. Chemical and Pharmaceutical Company · CH

Inventors

• Giancarlo Santus · Milano, IT
• Giuseppe Bottoni · Bologna, IT
• Ettore Bilato · Padova, IT

Key dates

• Filing date: Feb 1, 1995
• Grant date: Dec 25, 2001
• Expiry date: Feb 1, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P29/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An analgesic/anti-inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being an intranasally administrable dosage form.